Chugai Pharmaceutical Co., Ltd. (4519)

4,807.0 +59.0 (+1.24%)
Close JPY Disclaimer

4519 Financial Summary

For the three months ended 31 March 2022, Chugai Pharmaceutical Co Ltd revenues increased from Y168.82B to Y360.55B. Net income applicable to common stockholders increased from Y47.41B to Y131.78B. Revenues reflect Other foreign segment increase from Y5.39B to Y98.58B, Japan segment increase of 71% to Y162.71B. Net income benefited from Other Financial Income increase from Y285M to Y1.61B (income).
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
4519
Gross margin TTM 67.67%
Operating margin TTM 42.54%
Net Profit margin TTM 31.5%
Return on Investment TTM 20.9%
Total Revenue
Net Income
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Total Revenue 236,949 257,898 267,417
Gross Profit 163,999 179,642 175,755
Operating Income 99,873 106,687 112,614
Net Income 74,401 77,573 83,193
Clear All
0Selected
Please try another search
4519
Quick Ratio MRQ 4.2
Current Ratio MRQ 5.53
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
Total Assets
Total Liabilities
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Total Assets 1,897,764 1,932,547 1,817,649 1,831,590
Total Liabilities 255,717 306,967 282,657 318,266
Total Equity 1,642,047 1,625,580 1,534,992 1,513,324
Clear All
0Selected
Please try another search
4519
Cash Flow/Share TTM 232.83
Revenue/Share TTM 629.7
Operating Cash Flow 42.23%
Cash
Net Change in Cash
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Cash From Operating Activities 100,913 31,295 126,672
Cash From Investing Activities -32,244 1,992 -9,555
Cash From Financing Activities -66,872 -67,384 -2,366
Net Change in Cash 4,189 -33,675 117,330
Clear All
0Selected
Please try another search

* In Millions of JPY (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles